Why Did Super Micro Stock Fall So Much?
Super Micro Computer (NASDAQ:SMCI) was once a highly popular stock…
Sell
32
PETS Quote, Financials, Valuation and Earnings
Last price:
$4.17
Seasonality move
:
18.61%
Day range:
$4.06 - $4.17
52-week range:
$2.90 - $6.85
Dividend yield:
0%
P/E ratio:
410.00x
P/S ratio:
0.34x
P/B ratio:
0.88x
Volume:
129.8K
Avg. volume:
248.6K
1-year change:
-15.81%
Market cap:
$84.7M
Revenue:
$281.1M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PETS
PetMed Express
|
$60M | -- | -18.8% | -- | $3.75 |
|
CDT
Conduit Pharmaceuticals
|
-- | -- | -- | -- | -- |
|
LENZ
LENZ Therapeutics
|
-- | -$0.40 | -- | -82.44% | $42.63 |
|
ORKA
Oruka Therapeutics
|
-- | -$0.98 | -- | -35.68% | $39.86 |
|
TBRG
TruBridge
|
$84.4M | $0.38 | 3.62% | -28.23% | $29.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PETS
PetMed Express
|
$4.10 | $3.75 | $84.7M | 410.00x | $0.30 | 0% | 0.34x |
|
CDT
Conduit Pharmaceuticals
|
$0.85 | -- | $1.3M | -- | $0.00 | 0% | -- |
|
LENZ
LENZ Therapeutics
|
$26.09 | $42.63 | $718.6M | -- | $1.03 | 0% | -- |
|
ORKA
Oruka Therapeutics
|
$11.39 | $39.86 | $426.4M | -- | $0.00 | 0% | -- |
|
TBRG
TruBridge
|
$27.70 | $29.20 | $411.9M | -- | $0.00 | 0% | 1.16x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PETS
PetMed Express
|
-- | 1.321 | -- | 1.09x |
|
CDT
Conduit Pharmaceuticals
|
-- | 3.331 | -- | -- |
|
LENZ
LENZ Therapeutics
|
-- | 3.625 | -- | -- |
|
ORKA
Oruka Therapeutics
|
-- | 0.000 | -- | -- |
|
TBRG
TruBridge
|
50.42% | 2.763 | 58.38% | 1.34x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PETS
PetMed Express
|
$14.9M | -$450K | 0.37% | 0.37% | -0.85% | -$1.9M |
|
CDT
Conduit Pharmaceuticals
|
-- | -$5.8M | -- | -- | -- | -$2M |
|
LENZ
LENZ Therapeutics
|
-- | -$15.2M | -- | -- | -- | -$9.2M |
|
ORKA
Oruka Therapeutics
|
-- | -$29.4M | -- | -- | -- | -- |
|
TBRG
TruBridge
|
$49.8M | $9.2M | -5.67% | -11.47% | 8.1% | $6.1M |
PetMed Express vs. Competitors
-
Which has Higher Returns PETS or CDT?
Conduit Pharmaceuticals has a net margin of -1.33% compared to PetMed Express's net margin of --. PetMed Express's return on equity of 0.37% beat Conduit Pharmaceuticals's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PETSPetMed Express28.14% -$0.03 $96.2M CDTConduit Pharmaceuticals-- -$0.07 -- -
What do Analysts Say About PETS or CDT?
PetMed Express has a consensus price target of $3.75, signalling downside risk potential of -8.54%. On the other hand Conduit Pharmaceuticals has an analysts' consensus of -- which suggests that it could fall by --. Given that PetMed Express has higher upside potential than Conduit Pharmaceuticals, analysts believe PetMed Express is more attractive than Conduit Pharmaceuticals.
Company Buy Ratings Hold Ratings Sell Ratings PETSPetMed Express0 1 1 CDTConduit Pharmaceuticals0 0 0 -
Is PETS or CDT More Risky?
PetMed Express has a beta of 0.786, which suggesting that the stock is 21.429% less volatile than S&P 500. In comparison Conduit Pharmaceuticals has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PETS or CDT?
PetMed Express has a quarterly dividend of $0.30 per share corresponding to a yield of 0%. Conduit Pharmaceuticals offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetMed Express pays -166.63% of its earnings as a dividend. Conduit Pharmaceuticals pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PETS or CDT?
PetMed Express quarterly revenues are $53M, which are larger than Conduit Pharmaceuticals quarterly revenues of --. PetMed Express's net income of -$707K is higher than Conduit Pharmaceuticals's net income of -$6.5M. Notably, PetMed Express's price-to-earnings ratio is 410.00x while Conduit Pharmaceuticals's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetMed Express is 0.34x versus -- for Conduit Pharmaceuticals. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PETSPetMed Express0.34x 410.00x $53M -$707K CDTConduit Pharmaceuticals-- -- -- -$6.5M
-
Which has Higher Returns PETS or LENZ?
LENZ Therapeutics has a net margin of -1.33% compared to PetMed Express's net margin of --. PetMed Express's return on equity of 0.37% beat LENZ Therapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PETSPetMed Express28.14% -$0.03 $96.2M LENZLENZ Therapeutics-- -$0.46 -- -
What do Analysts Say About PETS or LENZ?
PetMed Express has a consensus price target of $3.75, signalling downside risk potential of -8.54%. On the other hand LENZ Therapeutics has an analysts' consensus of $42.63 which suggests that it could grow by 63.38%. Given that LENZ Therapeutics has higher upside potential than PetMed Express, analysts believe LENZ Therapeutics is more attractive than PetMed Express.
Company Buy Ratings Hold Ratings Sell Ratings PETSPetMed Express0 1 1 LENZLENZ Therapeutics5 0 0 -
Is PETS or LENZ More Risky?
PetMed Express has a beta of 0.786, which suggesting that the stock is 21.429% less volatile than S&P 500. In comparison LENZ Therapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PETS or LENZ?
PetMed Express has a quarterly dividend of $0.30 per share corresponding to a yield of 0%. LENZ Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $1.03 per share. PetMed Express pays -166.63% of its earnings as a dividend. LENZ Therapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PETS or LENZ?
PetMed Express quarterly revenues are $53M, which are larger than LENZ Therapeutics quarterly revenues of --. PetMed Express's net income of -$707K is higher than LENZ Therapeutics's net income of -$12.7M. Notably, PetMed Express's price-to-earnings ratio is 410.00x while LENZ Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetMed Express is 0.34x versus -- for LENZ Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PETSPetMed Express0.34x 410.00x $53M -$707K LENZLENZ Therapeutics-- -- -- -$12.7M
-
Which has Higher Returns PETS or ORKA?
Oruka Therapeutics has a net margin of -1.33% compared to PetMed Express's net margin of --. PetMed Express's return on equity of 0.37% beat Oruka Therapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PETSPetMed Express28.14% -$0.03 $96.2M ORKAOruka Therapeutics-- -$1.46 -- -
What do Analysts Say About PETS or ORKA?
PetMed Express has a consensus price target of $3.75, signalling downside risk potential of -8.54%. On the other hand Oruka Therapeutics has an analysts' consensus of $39.86 which suggests that it could grow by 249.93%. Given that Oruka Therapeutics has higher upside potential than PetMed Express, analysts believe Oruka Therapeutics is more attractive than PetMed Express.
Company Buy Ratings Hold Ratings Sell Ratings PETSPetMed Express0 1 1 ORKAOruka Therapeutics7 0 0 -
Is PETS or ORKA More Risky?
PetMed Express has a beta of 0.786, which suggesting that the stock is 21.429% less volatile than S&P 500. In comparison Oruka Therapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PETS or ORKA?
PetMed Express has a quarterly dividend of $0.30 per share corresponding to a yield of 0%. Oruka Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetMed Express pays -166.63% of its earnings as a dividend. Oruka Therapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PETS or ORKA?
PetMed Express quarterly revenues are $53M, which are larger than Oruka Therapeutics quarterly revenues of --. PetMed Express's net income of -$707K is higher than Oruka Therapeutics's net income of -$28.6M. Notably, PetMed Express's price-to-earnings ratio is 410.00x while Oruka Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetMed Express is 0.34x versus -- for Oruka Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PETSPetMed Express0.34x 410.00x $53M -$707K ORKAOruka Therapeutics-- -- -- -$28.6M
-
Which has Higher Returns PETS or TBRG?
TruBridge has a net margin of -1.33% compared to PetMed Express's net margin of -3.37%. PetMed Express's return on equity of 0.37% beat TruBridge's return on equity of -11.47%.
Company Gross Margin Earnings Per Share Invested Capital PETSPetMed Express28.14% -$0.03 $96.2M TBRGTruBridge54.8% -$0.38 $340.3M -
What do Analysts Say About PETS or TBRG?
PetMed Express has a consensus price target of $3.75, signalling downside risk potential of -8.54%. On the other hand TruBridge has an analysts' consensus of $29.20 which suggests that it could grow by 5.42%. Given that TruBridge has higher upside potential than PetMed Express, analysts believe TruBridge is more attractive than PetMed Express.
Company Buy Ratings Hold Ratings Sell Ratings PETSPetMed Express0 1 1 TBRGTruBridge2 2 0 -
Is PETS or TBRG More Risky?
PetMed Express has a beta of 0.786, which suggesting that the stock is 21.429% less volatile than S&P 500. In comparison TruBridge has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.717%.
-
Which is a Better Dividend Stock PETS or TBRG?
PetMed Express has a quarterly dividend of $0.30 per share corresponding to a yield of 0%. TruBridge offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetMed Express pays -166.63% of its earnings as a dividend. TruBridge pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PETS or TBRG?
PetMed Express quarterly revenues are $53M, which are smaller than TruBridge quarterly revenues of $90.8M. PetMed Express's net income of -$707K is higher than TruBridge's net income of -$3.1M. Notably, PetMed Express's price-to-earnings ratio is 410.00x while TruBridge's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetMed Express is 0.34x versus 1.16x for TruBridge. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PETSPetMed Express0.34x 410.00x $53M -$707K TBRGTruBridge1.16x -- $90.8M -$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Diamondback Energy a Good Stock to Buy?
Diamondback Energy (FANG) is a lesser-known diamond in the rough…
What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
68
WOR alert for Mar 27
Worthington Enterprises [WOR] is up 0.1% over the past day.
Sell
42
COCO alert for Mar 27
The Vita Coco [COCO] is down 4.28% over the past day.
Sell
14
VRT alert for Mar 27
Vertiv Holdings [VRT] is down 5.4% over the past day.
